In addition, SB431542, a TGF-β1 receptor inhibitor, reversed the TAM-type promotion effects, indicating that the GRP78-overexpressing gastric cancer cells promoted TAM-type macrophages through the TGF-β1 signaling pathway (Figure 4B–D). This evidence concerns the gene HSPA5 and gastric cancer.